Kim Turcotte

Senior Consultant, HTA and Medical Liaison

Dr. Kim Turcotte is a practicing physician and Medical Liaison at IMAC, bringing a powerful combination of clinical expertise, medical writing proficiency, and strategic insight to her work. With over a decade of experience, she specializes in developing compelling value messaging and comprehensive reimbursement dossiers for rare diseases, leading to successful submissions with global health technology assessment agencies, including NICE, TLV, SMC, MHRA, AMCP, INESSS, and CDA.

Her extensive medical background spans multiple therapeutic areas, including oncology, neurology, gastroenterology, dermatology, rheumatology, hematology, endocrinology, cardiology, psychiatry, and rare diseases. Dr. Turcotte completed her medical residency in the United States before returning to Canada to practice as a family physician. Her deep clinical knowledge, patient-centered approach, and strategic acumen make her an invaluable bridge between medicine and market access, ensuring that ground-breaking therapies reach the patients who need them most.